"Black Box WARNING"...How might that go...
This drug is non-chemo, has an excellent safety profile, is extremely well tolerated, while offering an efficacy at least twice that of the current drug being used for those unable to have or unwilling to have their bladder removed.
Furthermore, the company manufacturing and selling the existing inferior option is already our partner and is a major US player.
I would partner with ENDO for the US and let them talk to the FDA....just say'n
GLTA
Sqr